Lobbying client
REMPEX PHARMACEUTICALS, INC.
A pharmaceutical company focused on antibacterial drug discovery and development
The register keeps a separate record of this client for every firm that files for it and every spelling of its name. All 2 of its records are shown together here.
Filings
13
Filed by
2
Reported in-house
—
Reported by firms
$230,000
Reported lobbying by year
The larger of in-house and firm-reported each year, $ thousands
2012 to 2014
Filings
2 filings for 2014, newest first.
| Filing | Filed by | Amount |
|---|---|---|
|
2nd Quarter - Termination (No Activity) 2nd Quarter 2014
|
THE CONAFAY GROUP, LLC | — reported |
|
1st Quarter - Report (No Activity) 1st Quarter 2014
|
THE CONAFAY GROUP, LLC | $90,000 reported |
Filed by
Each firm that has reported for this client, and the client itself where it lobbies in-house, with the reports filed and the amounts they disclose.
| Firm | Reports | Amount |
|---|---|---|
| THE CONAFAY GROUP, LLC | 7 | $120,000 |
| FABIANI & COMPANY | 3 | $110,000 |
Issues lobbied
How many report sections named each issue, counting the current version of each report.
| Issue | Code | Mentions |
|---|---|---|
| Medical/Disease Research/Clinical Labs | MED | 4 |
| Health Issues | HCR | 3 |
From reports filed under the Lobbying Disclosure Act. Firms report what each client paid them; an organisation lobbying for itself reports its own expenses. Amounts count the current version of each report once.